Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice

Aging

Volumn 6, Issue 7, 2014, Pages 575-586

  Stout, Michael B ^a   Tchkonia, Tamara ^a   Pirtskhalava, Tamar ^a   Palmer, Allyson K ^a   List, Edward O ^b   Berryman, Darlene E ^b   Lubbers, Ellen R ^b   Escande, Carlos ^a   Spong, Adam ^c   Masternak, Michal M ^d   Oberg, Ann L ^a   LeBrasseur, Nathan K ^a   Miller, Richard A ^e   Kopchick, John J ^b   Bartke, Andrzej ^c   Kirkland, James L ^a  

^a MAYO CLINIC   (United States)

^b OHIO UNIVERSITY   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adipose tissue; Aging; Cellular senescence; Growth hormone

Indexed keywords

GROWTH HORMONE; MESSENGER RNA;

ADIPOCYTE; AGING; ANIMAL; CELL AGING; CELL DIFFERENTIATION; CYTOLOGY; INBRED MOUSE STRAIN; LIPID METABOLISM; MOUSE; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; AGING; ANIMALS; CELL AGING; CELL DIFFERENTIATION; GROWTH HORMONE; LIPID METABOLISM; MICE; MICE, INBRED STRAINS; MUTATION; RNA, MESSENGER;

EID: 84905705301     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100681     Document Type: Article

References (70)

1. Bartke A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology. 2003; 78:2100-216.
2. Ayuk J and Sheppard MC. Does acromegaly enhance mortality? Rev Endocr Metab Disord. 2008; 9:33-39.
3. Everitt AV, Seedsman NJ and Jones F. The effects of hypophysectomy and continuous food restriction, begun at ages 70 and 400 days, on collagen aging, proteinuria, incidence of pathology and longevity in the male rat. Mech Ageing Dev. 1980; 12:161-172.
4. Shimokawa I, Higami Y, Utsuyama M, Tuchiya T, Komatsu T, Chiba T and Yamaza H. Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model. Am J Pathol. 2002; 160:2259-2265.
5. Brown-Borg HM, Borg KE, Meliska CJ and Bartke A. Dwarf mice and the ageing process. Nature. 1996; 384(6604):33.
6. Flurkey K, Papaconstantinou J, Miller RA and Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A. 2001; 98:6736-6741.
7. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A and Kopchick JJ. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology. 2003; 144:3799-3810.
8. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S, de Cabo R, Cohen P and Longo VD. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011; 3:70ra13.
9. Milman S, Atzmon G, Huffman DM, Wan J, Crandall JP, Cohen P and Barzilai N. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging Cell. 2014; epub ahead of print.
10. Bartke A, Sun LY and Longo V. Somatotropic signaling: tradeoffs between growth, reproductive development, and longevity. Physiol Rev. 2013; 93:571-598.
11. Andersen B, Pearse RV, 2nd, Jenne K, Sornson M, Lin SC, Bartke A and Rosenfeld MG. The Ames dwarf gene is required for Pit-1 gene activation. Dev Biol. 1995; 172:495-503.
12. Li S, Crenshaw EB, 3rd, Rawson EJ, Simmons DM, Swanson LW and Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature. 1990; 347:528-533.
13. Junnila RK, List EO, Berryman DE, Murrey JW and Kopchick JJ. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol. 2013; 9:366-376.
14. List EO, Sackmann-Sala L, Berryman DE, Funk K, Kelder B, Gosney ES, Okada S, Ding J, Cruz-Topete D and Kopchick JJ. Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. Endocr Rev. 2011; 32:356-386.
15. Palmer AJ, Chung MY, List EO, Walker J, Okada S, Kopchick JJ and Berryman DE. Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology. 2009; 150:1353-1360.
16. Baker DJ, Jeganathan KB, Malureanu L, Perez-Terzic C, Terzic A and van Deursen JM. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J Cell Biol. 2006; 172:529-540.
17. DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK and Poehlman ET. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care. 2001; 24:925-932.
18. Hughes VA, Roubenoff R, Wood M, Frontera WR, Evans WJ and Fiatarone Singh MA. Anthropometric assessment of 10-y changes in body composition in the elderly. Am J Clin Nutr. 2004; 80:475-482.
19. Djian P, Roncari AK and Hollenberg CH. Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture. J Clin Invest. 1983; 72:1200- 1208.
20. Kirkland JL and Hollenberg CH. Inhibitors of preadipocyte replication: opportunities for the treatment of obesity. Prog Mol Subcell Biol. 1998; 20:177-195.
21. Kirkland JL, Hollenberg CH and Gillon WS. Age, anatomic site, and the replication and differentiation of adipocyte precursors. Am J Physiol. 1990; 258:C206-210.
22. Schipper BM, Marra KG, Zhang W, Donnenberg AD and Rubin JP. Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg. 2008; 60:538-544.
23. Karagiannides I, Tchkonia T, Dobson DE, Steppan CM, Cummins P, Chan G, Salvatori K, Hadzopoulou-Cladaras M and Kirkland JL. Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol Regul Integr Comp Physiol. 2001; 280:R1772-1780.
24. Karagiannides I, Thomou T, Tchkonia T, Pirtskhalava T, Kypreos KE, Cartwright A, Dalagiorgou G, Lash TL, Farmer SR, Timchenko NA and Kirkland JL. Increased CUG triplet repeatbinding protein-1 predisposes to impaired adipogenesis with aging. J Biol Chem. 2006; 281:23025-23033.
25. Tchkonia T, Pirtskhalava T, Thomou T, Cartwright MJ, Wise B, Karagiannides I, Shpilman A, Lash TL, Becherer JD and Kirkland JL. Increased TNFalpha and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis. Am J Physiol Endocrinol Metab. 2007; 293:E1810-1819.
26. Morin CL, Pagliassotti MJ, Windmiller D and Eckel RH. Adipose tissue-derived tumor necrosis factor-alpha activity is elevated in older rats. J Gerontol A Biol Sci Med Sci. 1997; 52:B190-195.
27. Cartwright MJ, Schlauch K, Lenburg ME, Tchkonia T, Pirtskhalava T, Cartwright A, Thomou T and Kirkland JL. Aging, depot origin, and preadipocyte gene expression. J Gerontol A Biol Sci Med Sci. 2010; 65:242-251.
28. Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, Khosla S, Jensen MD and Kirkland JL. Fat tissue, aging, and cellular senescence. Aging Cell. 2010; 9:667- 684.
29. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY and Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008; 6:2853-2868.
30. Freund A, Orjalo AV, Desprez PY and Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010; 16:238-246.
31. Parrinello S, Coppe JP, Krtolica A and Campisi J. Stromalepithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci. 2005; 118:485-496.
32. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C and Lowe SW. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 2007; 445:656-660.
33. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL and van Deursen JM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236.
34. Wang Z, Al-Regaiey KA, Masternak MM and Bartke A. Adipocytokines and lipid levels in Ames dwarf and calorierestricted mice. J Gerontol A Biol Sci Med Sci. 2006; 61:323-331.
35. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK and Kopchick JJ. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res. 2004; 14:309- 318.
36. Berryman DE, List EO, Palmer AJ, Chung MY, Wright-Piekarski J, Lubbers E, O'Connor P, Okada S and Kopchick JJ. Two-year body composition analyses of long-lived GHR null mice. J Gerontol A Biol Sci Med Sci. 2010; 65:31-40.
37. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005; 120:513-522.
38. Jeyapalan JC and Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev. 2008; 129:467-474.
39. Kirkland JL. Translating advances from the basic biology of aging into clinical application. Exp Gerontol. 2013; 48:1-5.
40. Kuk JL, Saunders TJ, Davidson LE and Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009; 8:339-348.
41. Guo SS, Zeller C, Chumlea WC and Siervogel RM. Aging, body composition, and lifestyle: the Fels Longitudinal Study. Am J Clin Nutr. 1999; 70:405-411.
42. Tchkonia T, Thomou T, Zhu Y, Karagiannides I, Pothoulakis C, Jensen MD and Kirkland JL. Mechanisms and Metabolic Implications of Regional Differences among Fat Depots. Cell Metab. 2013; 17:644-656.
43. Hauner H and Loffler G. Adipose tissue development: the role of precursor cells and adipogenic factors. Part I: Adipose tissue development and the role of precursor cells. Klin Wochenschr. 1987; 65:803-811.
44. Loffler G and Hauner H. Adipose tissue development: the role of precursor cells and adipogenic factors. Part II: The regulation of the adipogenic conversion by hormones and serum factors. Klin Wochenschr. 1987; 65:812-817.
45. Wabitsch M, Heinze E, Hauner H, Shymko RM, Teller WM, De Meyts P and Ilondo MM. Biological effects of human growth hormone in rat adipocyte precursor cells and newly differentiated adipocytes in primary culture. Metabolism. 1996; 45:34-42.
46. Wabitsch M, Hauner H, Heinze E and Teller WM. The role of growth hormone/insulin-like growth factors in adipocyte differentiation. Metabolism. 1995; 44:45-49.
47. Deslex S, Negrel R and Ailhaud G. Development of a chemically defined serum-free medium for differentiation of rat adipose precursor cells. Exp Cell Res. 1987; 168:15-30.
48. Rosen ED and MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol. 2006; 7:885-896.
49. Hotta K, Bodkin NL, Gustafson TA, Yoshioka S, Ortmeyer HK and Hansen BC. Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. J Gerontol A Biol Sci Med Sci. 1999; 54:B183-188.
50. Flint DJ, Binart N, Boumard S, Kopchick JJ and Kelly P. Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity. J Endocrinol. 2006; 191:101-111.
51. Masternak MM and Bartke A. Growth hormone, inflammation and aging. Pathobiol Aging Age Relat Dis. 2012; 2.
52. Blagosklonny MV. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging (Milano). 2012; 4:159-165.
53. Sousa-Victor P, Gutarra S, Garcia-Prat L, Rodriguez-Ubreva J, Ortet L, Ruiz-Bonilla V, Jardi M, Ballestar E, Gonzalez S, Serrano AL, Perdiguero E and Munoz-Canoves P. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature. 2014; 506:316-321.
54. Leontieva OV, Demidenko ZN and Blagosklonny MV. Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program. Proc Natl Acad Sci U S A. 2014; 111:8832-8837.
55. Leontieva OV, Demidenko ZN and Blagosklonny MV. S6K in geroconversion. Cell Cycle. 2013; 12:3249-3252.
56. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV and Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle. 2009; 8:1888-1895.
57. Leontieva OV, Demidenko ZN and Blagosklonny MV. MEK drives cyclin D1 hyperelevation during geroconversion. Cell Death Differ. 2013; 20:1241-1249.
58. Iglesias-Bartolome R and Gutkind JS. Exploiting the mTOR paradox for disease prevention. Oncotarget. 2012.
59. Luo Y, Li L, Zou P, Wang J, Shao L, Zhou D and Liu L. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence. Transplantation. 2014; 97:20-29.
60. Iglesias-Bartolome R, Patel V, Cotrim A, Leelahavanichkul K, Molinolo AA, Mitchell JB and Gutkind JS. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell. 2012; 11:401-414.
61. Blazer S, Khankin E, Segev Y, Ofir R, Yalon-Hacohen M, Kra-Oz Z, Gottfried Y, Larisch S and Skorecki KL. High glucose-induced replicative senescence: point of no return and effect of telomerase. Biochem Biophys Res Commun. 2002; 296:93-101.
62. Handayaningsih AE, Takahashi M, Fukuoka H, Iguchi G, Nishizawa H, Yamamoto M, Suda K and Takahashi Y. IGF-I enhances cellular senescence via the reactive oxygen speciesp53 pathway. Biochem Biophys Res Commun. 2012; 425:478- 484.
63. Tran D, Bergholz J, Zhang H, He H, Wang Y, Zhang Y, Li Q, Kirkland JL and Xiao Z-X. Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence. Aging Cell. 2014; epub ahead of print.
64. Matsui-Hirai H, Hayashi T, Yamamoto S, Ina K, Maeda M, Kotani H, Iguchi A, Ignarro LJ and Hattori Y. Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide. J Pharmacol Exp Ther. 2011; 337:591-599.
65. Masternak MM, Panici JA, Wang F, Wang Z and Spong A. The effects of growth hormone (GH) treatment on GH and insulin/IGF-1 signaling in long-lived Ames dwarf mice. J Gerontol A Biol Sci Med Sci. 2010; 65:24-30.
66. Panici JA, Harper JM, Miller RA, Bartke A, Spong A and Masternak MM. Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice. Faseb J. 2010; 24:5073-5079.
67. Escande C, Chini CC, Nin V, Dykhouse KM, Novak CM, Levine J, van Deursen J, Gores GJ, Chen J, Lou Z and Chini EN. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to highfat diet-induced liver steatosis in mice. J Clin Invest. 2010; 120:545-558.
68. Kirkland JL, Hollenberg CH and Gillon WS. Effects of fat depot site on differentiation-dependent gene expression in rat preadipocytes. Int J Obes Relat Metab Disord. 1996; 20 Suppl 3:S102-107.
69. Wang H, Kirkland JL and Hollenberg CH. Varying capacities for replication of rat adipocyte precursor clones and adipose tissue growth. J Clin Invest. 1989; 83:1741-1746.
70. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) Method. Methods. 2001; 25:402-408.